Update 1: Foreign Drug Stocks in Spotlight Foreign drug stocks were in the spotlight Thursday with Food and Drug Administration news pulling the sector down. AstraZeneca PLC took a drubbing on the eve of its FDA advisory panel meeting for its orally 